Prospective prevalence of pathologic gambling and medication association in Parkinson disease

Neurology

Volumn 66, Issue 11, 2006, Pages 1750-1752

  Voon, V ^a,b   Hassan, K ^b   Zurowski, M ^b   Duff Canning, S ^b   De Souza, M ^b   Fox, S ^b   Lang, A E ^b   Miyasaki, J ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG POTENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED SOUTH OAKS GAMBLING SCALE; ONSET AGE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE;

AGED; ANTIPARKINSON AGENTS; DOPAMINE AGENTS; FEMALE; GAMBLING; HUMANS; LEVODOPA; MALE; MIDDLE AGED; ONTARIO; PARKINSON DISEASE; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33745673846     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000218206.20920.4d     Document Type: Article

References (10)

1. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005;62:1377-1381.
2. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987;144:1184-1188.
3. Ferris J, Stirpe T, Ialomiteanu A. Gambling in Ontario: a report from a general population survey on gambling-related problems and opinions. Toronto: Addiction Research Foundation, 1996.
4. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000;95(suppl 2):S91-S117.
5. Gerlach M, Double K, Arzberger T, Leblhuber F, Tatschner T, Riederer P. Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 2003;110:1119-1127.
6. Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W. Pathological gambling: a review of biobehavioral findings. Neurosci Biobehav Rev 2004;28:123-141.
7. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005;8:147-148.
8. Menza M. The personality associated with Parkinson's disease. Curr Psychiatry Rep 2000;2:421-426.
9. Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003;299:1898-1902.
10. Cools R. Dopaminergic modulation of cognitive function - implications for 1-dopa treatment in Parkinson's disease. Neurosci Biobehav Rev 2006;30:1-23.